Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2015 Jan 23;2904:2303-11. doi: 10.1074/jbc.M114.581892.
Show Gene links
Show Anatomy links
Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.
Sasaki S
,
Futagi Y
,
Kobayashi M
,
Ogura J
,
Iseki K
.
???displayArticle.abstract???
Thyrotropin-releasing hormone is a tripeptide that consists of 5-oxoproline, histidine, and proline. The peptide is rapidly metabolized by various enzymes. 5-Oxoproline is produced by enzymatic hydrolysis in a variety of peptides. Previous studies showed that 5-oxoproline could become a possible biomarker for autism spectrum disorders. Here we demonstrate the involvement of SLC16A1 in the transport of 5-oxoproline. An SLC16A1 polymorphism (rs1049434) was recently identified. However, there is no information about the effect of the polymorphism on SLC16A1 function. In this study, the polymorphism caused an observable change in 5-oxoproline and lactate transport via SLC16A1. The Michaelis constant (Km) was increased in an SLC16A1 mutant compared with that in the wild type. In addition, the proton concentration required to produce half-maximal activation of transport activity (K0.5, H (+)) was increased in the SLC16A1 mutant compared with that in the wild type. Furthermore, we examined the transport of 5-oxoproline in T98G cells as an astrocyte cell model. Despite the fact that 5-oxoproline is an amino acid derivative, Na(+)-dependent and amino acid transport systems scarcely contributed to 5-oxoproline transport. Based on our findings, we conclude that H(+)-coupled 5-oxoproline transport is mediated solely by SLC16A1 in the cells.
Arjona,
Identification and functional characterization of zebrafish solute carrier Slc16a2 (Mct8) as a thyroid hormone membrane transporter.
2011, Pubmed
Arjona,
Identification and functional characterization of zebrafish solute carrier Slc16a2 (Mct8) as a thyroid hormone membrane transporter.
2011,
Pubmed
Bassiri,
Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
1973,
Pubmed
Ben-Zaken,
Differences in MCT1 A1470T polymorphism prevalence between runners and swimmers.
2015,
Pubmed
Cupeiro,
MCT1 genetic polymorphism influence in high intensity circuit training: a pilot study.
2010,
Pubmed
Emmett,
Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle.
2014,
Pubmed
Fedotovskaya,
A common polymorphism of the MCT1 gene and athletic performance.
2014,
Pubmed
Foltz,
A novel bifunctionality: PAT1 and PAT2 mediate electrogenic proton/amino acid and electroneutral proton/fatty acid symport.
2004,
Pubmed
,
Xenbase
Fujisawa,
Measurement of electric current evoked by substrate transport via bi-directional H+/oligopeptide transporter over-expressed in HeLa cells: electrogenic efflux and existence of a newly observed channel-like state.
2006,
Pubmed
Fujita,
Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2.
2004,
Pubmed
Ganapathy,
Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.
2008,
Pubmed
Gasque,
Identification and characterization of complement C3 receptors on human astrocytes.
1996,
Pubmed
Grioli,
Pyroglutamic acid improves the age associated memory impairment.
1990,
Pubmed
Groeneweg,
Importance of His192 in the human thyroid hormone transporter MCT8 for substrate recognition.
2013,
Pubmed
Groeneweg,
The role of Arg445 and Asp498 in the human thyroid hormone transporter MCT8.
2014,
Pubmed
Herculano-Houzel,
The remarkable, yet not extraordinary, human brain as a scaled-up primate brain and its associated cost.
2012,
Pubmed
Hildebrand,
Glucose metabolism transporters and epilepsy: only GLUT1 has an established role.
2014,
Pubmed
Kuwabara,
Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.
2013,
Pubmed
Lean,
Genetic variations in the MCT1 (SLC16A1) gene in the Chinese population of Singapore.
2009,
Pubmed
Lee,
Role of oxoproline in the regulation of neutral amino acid transport across the blood-brain barrier.
1996,
Pubmed
Lengacher,
Resistance to diet-induced obesity and associated metabolic perturbations in haploinsufficient monocarboxylate transporter 1 mice.
2013,
Pubmed
Lima de Souza,
Importance of cysteine residues in the thyroid hormone transporter MCT8.
2013,
Pubmed
Mao,
Differential transcriptional control of the superoxide dismutase-2 kappaB element in neurons and astrocytes.
2006,
Pubmed
Merezhinskaya,
Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport.
2000,
Pubmed
Miyauchi,
Sodium-coupled electrogenic transport of pyroglutamate (5-oxoproline) via SLC5A8, a monocarboxylate transporter.
2010,
Pubmed
,
Xenbase
Pharoah,
Relationship between maternal thyroxine levels during pregnancy and memory function in childhood.
1991,
Pubmed
Pillai,
SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes.
2011,
Pubmed
,
Xenbase
Sasaki,
Crucial residue involved in L-lactate recognition by human monocarboxylate transporter 4 (hMCT4).
2013,
Pubmed
,
Xenbase
Sawczuk,
MCT1 A1470T: a novel polymorphism for sprint performance?
2015,
Pubmed
Schindler,
Thyroid function and postmenopause.
2003,
Pubmed
Seki,
Heterologous expression of Pharaonis halorhodopsin in Xenopus laevis oocytes and electrophysiological characterization of its light-driven Cl- pump activity.
2007,
Pubmed
,
Xenbase
Selmi-Ruby,
The targeted inactivation of TRβ gene in thyroid follicular cells suggests a new mechanism of regulation of thyroid hormone production.
2014,
Pubmed
Stwertka,
TRH protection against memory retrieval deficits is independent of endocrine effects.
1992,
Pubmed
Suzuki,
Astrocyte-neuron lactate transport is required for long-term memory formation.
2011,
Pubmed
Takekuma,
Difference between pharmacokinetics of mycophenolic acid (MPA) in rats and that in humans is caused by different affinities of MRP2 to a glucuronized form.
2007,
Pubmed
,
Xenbase
Viljoen,
Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate.
2012,
Pubmed
Weng,
Identification of the essential histidine residue for high-affinity binding of AlbA protein to albicidin antibiotics.
2003,
Pubmed
de Vrieze,
Knockdown of monocarboxylate transporter 8 (mct8) disturbs brain development and locomotion in zebrafish.
2014,
Pubmed
Ávila Rodriguez,
Tibolone protects T98G cells from glucose deprivation.
2014,
Pubmed
